Kala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. TSLA
4. NVDA
5. AWK
6. GNK
7. USO
8. ARGX
9. SPCX
10. AZN

Go back to Kala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Kala Pharmaceuticals (KALA) Misses Q3 EPS by 6c, Revenues Beat

November 5, 2020 8:43 AM EST

Kala Pharmaceuticals (NASDAQ: KALA) reported Q3 EPS of ($0.50), $0.06 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $2.22 million versus the consensus estimate of $2.01 million.

We are pleased with our third quarter results and the fourth quarter of 2020... More